ArticleBMJ public health2025
Health-related quality of life among adult hypertensive patients globally: a systematic review and meta-analysis.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Quality of life and associated factors among people living with hypertension in a tertiary hospital of Kathmandu District, Nepal.BMC cardiovascular disorders · 2026Article
- Lifestyle Habits and Comorbidities as Determinants of Quality of Life in Coronary Artery Disease: A Single-Center Prospective Study.Journal of clinical medicine · 2026Article
- Effectiveness of garlic clove (Bioinformation · 2026Article
- Predictors of Illness Acceptance Among Hypertensive Patients in Freetown: A Multivariate Analysis of Sociodemographic, Religiosity, and Quality of Life Factors.Journal of primary care & community healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractObjective: This study aimed to assess the quality of life of hypertensive patients in the world. Design: Systematic review and meta-analysis using observational studies was done. Data sources: EMBASE, Scopus, PubMed/MEDLINE, Google Scholar and published and unpublished articles were used. Eligibility criteria: Observational studies reporting Health Related Quality of Life among hypertensive adults (>18 years) were included. Published studies, relevant abstracts and grey literature in English up to May 2024 were considered. Studies without the outcome of interest, inaccessible even after two email attempts, case reports, low-quality papers and review articles were excluded. Data extraction and synthesis: The data were extracted and cleaned using Microsoft Excel and analysed by STATA V.17. The protocol has been registered in the International Prospective Register of Systematic Reviews (PROSPERO) and given ID No. CRD42024562674.A random-effect meta-analysis technique was employed. The heterogeneity of the studies was assessed using Cochrane I Results: This review includes 22 studies with a total of 5447 study participants. The pooled mean SF-36 scores for hypertensive adults were 60.0 (95% CI 54.6 to 65.4) for physical component summary (PCS) and 60.1 (95% CI 54.2 to 66.1) for mental component summary (MCS). Based on trim-and-fill analysis, the bias-adjusted mean scores were 52.3% (95% CI 47.1% to 57.5%) for PCS and 46.4% (95% CI 41.3%-51.5%) for MCS. Conclusions: This meta-analysis revealed a significant negative impact of hypertension on both physical and mental health-related quality of life. The predicted mean scores, however, dropped to 52.3% for PCS and 46.4% for MCS after correcting for any publication bias using the trim-and-fill analysis. These findings warrant attention from health professionals, government officials, policymakers and the WHO. PROSPERO registration number: CRD42024562674.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.